Genomic study of congenital sideroblastic anemias
Part of Blood & lymphatic clinical trials.
This trial studies the genes of people with a rare type of inherited anemia called congenital sideroblastic anemia, where the body has trouble making healthy red blood cells. It aims to find new genetic causes by looking at genes involved with the cell's energy centers (mitochondria).
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a type of inherited anemia known as congenital sideroblastic anemia that started at birth.
- Standard genetic tests have not found the cause of your anemia.
- You have changes in both copies of a gene that helps your mitochondria work, identified through a special type of genetic test called exome sequencing.
- You may have participated in the past or be identified in the next 12 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a drug called luspatercept to see if it can improve anemia in people with rare inherited red blood cell disorders. It may help reduce the need for blood transfusions or raise hemoglobin levels.
This trial aims to improve how doctors diagnose rare inherited anemias, including sickle cell disease and other conditions that destroy red blood cells. It may help if you have a confirmed or suspected diagnosis but need more clarity through advanced testing.
This study looks at genetic (DNA) factors that may contribute to certain blood disorders. You may be invited if you or a close family member is receiving care for a blood condition like MDS or MPN, and the study also includes related relatives.
This study looks at how your genes can affect inherited blood conditions like sickle cell disease and thalassemia. It may help researchers understand why symptoms differ from person to person, which could guide better future treatments.
This research study helps doctors identify the genetic reason why some people have hemolytic anemia (a condition where red blood cells break down too quickly). Researchers will study patients with this condition and their family members to understand the underlying cause and potentially improve diagnosis and treatment.
This study looks at how red blood cells work in people who have a related condition—or who have family members with one. It may help researchers understand causes of these diseases and improve future care.
Hear when a new Anemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.